CN109917144A - A kind of preparation method and applications of methoxyepinephrine specific antibody - Google Patents

A kind of preparation method and applications of methoxyepinephrine specific antibody Download PDF

Info

Publication number
CN109917144A
CN109917144A CN201910297156.3A CN201910297156A CN109917144A CN 109917144 A CN109917144 A CN 109917144A CN 201910297156 A CN201910297156 A CN 201910297156A CN 109917144 A CN109917144 A CN 109917144A
Authority
CN
China
Prior art keywords
methoxyepinephrine
specific antibody
sample
antibody
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201910297156.3A
Other languages
Chinese (zh)
Inventor
代春迎
田晓平
侯鹏云
赵巧辉
李桂林
付光宇
吴学炜
杨增利
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Zhengzhou Immuno Biotech Co Ltd
Original Assignee
Zhengzhou Immuno Biotech Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zhengzhou Immuno Biotech Co Ltd filed Critical Zhengzhou Immuno Biotech Co Ltd
Priority to CN201910297156.3A priority Critical patent/CN109917144A/en
Publication of CN109917144A publication Critical patent/CN109917144A/en
Pending legal-status Critical Current

Links

Landscapes

  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

The invention discloses a kind of preparation methods of methoxyepinephrine specific antibody, the methoxyepinephrine specific antibody is using methoxyepinephrine coupling carrier albumen preparation artificial antigen as immunogene, and immunization experiment animal obtains.The present invention uses methoxyepinephrine coupling carrier albumen as immunogene, it is prepared for the antibody of the anti-methoxyepinephrine of specificity, the ELISA kit of methoxyepinephrine in detection sample is established with specific antibody prepared by the present invention, with adrenaline, norepinephrine, dopamine, metanephrine no cross reaction, the methoxyepinephrine content in sample can be rapidly and accurately detected, has higher sensitivity and specificity.

Description

A kind of preparation method and applications of methoxyepinephrine specific antibody
Technical field
The present invention relates to vitro diagnostic techniques, more particularly, to a kind of system of methoxyepinephrine specific antibody Preparation Method, the invention further relates to the specific antibody prepared detection sample in methoxyepinephrine content kit In application.
Background technique
Chromaffin cell tumor (Pheochromocytoma, PHEO) be mainly derived from adrenal medella, sympathetic ganglion or The thermophilic network tissue at other positions.Diagnosis chromaffin cell tumor outstanding feature object include catecholamine (Catecholamine, CA) and Its metabolin metanephrine (Metanephrine, MN), methoxyepinephrine (Normetanephrine, NMN).
Detection blood plasma or catecholamine in urine and its metabolin such as MN and NMN are that clinically to diagnose thermophilic network thin at present The main method of born of the same parents' tumor.Common detection method includes high performance liquid chromatography (HPLC), capillary electrophoresis (CE), mass spectrography (MS), gas chromatography (GC), biochemical method and enzyme linked immunosorbent assay (ELISA) etc..When clinical use, these methods respectively have Advantage and disadvantage, HPLC method result precision is high, but takes a long time, higher cost;Biochemical method and enzyme linked immunosorbent assay are easy to operate, But specificity and sensitivity still need to further increase.
Summary of the invention
The purpose of the present invention is to provide a kind of preparation method of methoxyepinephrine specific antibody, You Benfa The methoxyepinephrine detection kit that the antibody of bright preparation is established, can fast and accurately detect the methoxy in sample Base Noradrenaline Contents.
To achieve the above object, the present invention can take following technical proposals:
The preparation method of methoxyepinephrine specific antibody of the present invention, the methoxyepinephrine Specific antibody is that artificial antigen is prepared using methoxyepinephrine coupling carrier albumen as immunogene, and immunization experiment is dynamic Object obtains;The immunogene specific the preparation method comprises the following steps:
Carrier protein is dissolved as 4mg/ml with the MES buffer of 0.05mol/L, pH=4.7 by the first step;With 0.05mol/L, pH 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride salt is 20mg/ml by=4.7 MES buffer;With Methoxyepinephrine is dissolved as 2mg/ml by the MES buffer of 0.05mol/L, pH=4.7;
Second step, by methoxyepinephrine and carrier protein according to 200:1(W/W) ratio be added reaction cup in, room temperature It mixes, according to 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride: methoxyepinephrine=1:50(W/W) Ratio calculate the dosage of 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride, room temperature is slowly added in reaction cup, Room temperature is protected from light overnight;
Third step, 12h that reaction solution dialysed in 4 DEG C of environment with the PBS buffer solution of 0.01mol/L, pH=7.2 is to get to immune It is former.
The carrier protein is bovine serum albumin(BSA) (BSA), keyhole limpet hemocyanin (KLH), oralbumin (OVA) etc.. Conventional animal model, such as mouse, cavy, rabbit, goat, sheep or horse can be used in experimental animal used.
Methoxyepinephrine specific antibody of the present invention is preparing methoxyepinephrine detection Application in kit: the antibody of preparation is coated on solid phase carrier, is handled sample with biotinylated acylating agent, The methoxyepinephrine after being acylated in sample is set to be identified and be combined by the antibody on solid phase carrier;Wash away unbonded acyl After agent, the Avidin for using horseradish peroxidase-labeled is added;After washing again, substrate solution, quantitative detection sample is added In methoxyepinephrine content.
The solid phase carrier can be magnetic particle or microwell plate;The acylating agent can be 6-(dimaleoyl imino) Caproic acid succinimide ester, N- [6-(biotin amino) caproyl] -6-aminocaprolc acid N- succinimide ester, N- succinyl are sub- Amino 6- biotin lpsilon etc..
The sample is serum, blood plasma or urine.
The advantage of the invention is that using methoxyepinephrine coupling carrier albumen as immunogene, it is prepared for spy The antibody of anisotropic anti-methoxyepinephrine establishes methoxyl group in detection sample with specific antibody prepared by the present invention The ELISA kit of norepinephrine, with adrenaline, norepinephrine, dopamine, metanephrine without intersecting Reaction, can rapidly and accurately detect the methoxyepinephrine content in sample, have higher sensitivity and special Property.
Detailed description of the invention
Fig. 1 is that the detection kit established with antibody of the present invention is illustrated with HPLC detection method correlation.
Specific embodiment
More detailed explanation is made to the method for the present invention below by specific embodiment, in order to those skilled in the art couple The understanding of the application.Unless otherwise specified, reagent use herein and instrument are this field conventional products, in the application Test method used is also conventional method in this field.
Embodiment 1 prepares methoxyepinephrine immunogene (carrier protein selects KLH)
KLH is dissolved as 4mg/ml with the MES buffer of 0.05mol/L, pH=4.7 by the first step;With 0.05mol/L, pH=4.7 MES buffer by 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride salt be 20mg/ml;Use 0.05mol/ L, methoxyepinephrine is dissolved as 2mg/ml by the MES buffer of pH=4.7;
Second step, by methoxyepinephrine and KLH according to 200:1(W/W) ratio be added reaction cup in, room temperature mix, According to 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride: methoxyepinephrine=1:50(W/W) ratio Example calculates the dosage of 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride, and room temperature is slowly added in reaction cup, room temperature It is protected from light overnight;
Third step, 12h that reaction solution dialysed in 4 DEG C of environment with the PBS buffer solution of 0.01mol/L, pH=7.2 is to get to immune It is former.
Embodiment 2 prepares methoxyepinephrine specific antibody (experimental animal model selection New Zealand great Bai Rabbit)
By the immunogene Freund's complete adjuvant prepared in embodiment 1 it is fully emulsified after, subcutaneous multiple spot is 2.5kg or so to weight Male New Zealand White Rabbit be immunized, first immunisation dosage be 2mg/ only;28 days, 56 days difference are spaced after immune for the first time It carries out for the second time and third time is immune, immunogene and incomplete Freund's adjuvant are mixed after emulsifying in equal volume and be immunized, and immunizing dose is 1mg/ is only.After 3rd time 10 days immune, rabbit ear vein blood sampling, polyvalent antibody Protein A column is purified, and it is anti-to obtain specificity Methoxyepinephrine polyclonal antibody.
Embodiment 3 establishes methoxyepinephrine ELISA detection kit, and (selection of its solid phase carrier is micro- using magnetic Grain)
1, magnetic particle is coated with
Magnetic particle stoste after taking 30 μ l to mix is washed 5 times with the PBS buffer solution of 300 μ l, then with 10% glutaraldehyde to magnetic Activating microparticles 1 hour, then the magnetic particle after activation is washed 2 times with 7~8 PBS buffer solution of pH;Methoxyl group is gone on first kidney Parathyrine antibody is added in magnetic bead according to the amount of 0.3 μ g/ person-portion, and 4 DEG C are coated with 2 hours.It is finally small with the confining liquid closing 2 containing BSA When, 2-8 DEG C of magnetic bead after closing saves backup.
2, the pre-treatment of sample
It takes urine specimen 50ul to be added in reaction cup, the hydrochloric acid 300ul of 0.1mol/L is added, after sample mixes at 60 DEG C of acidifications 2h is managed, the biotinylated 6-(dimaleoyl imino of 100ul is added after being cooled to room temperature) caproic acid succinimide ester, room temperature acyl It is detected after changing processing 30min.
3, pattern detection
The chromaffin cell tumor clinical samples 40 with HPLC method definite value from hospital are collected, take 50ul after acylated processing It is transferred in another reaction cup, the magnetic particle that addition is coated with anti-methoxyepinephrine antibody in each reaction cup hangs Liquid 20ul, 37 DEG C of reaction 15min after mixing;It is washed 5 times after reaction, the Avidin of HRP label is added in each reaction cup 100ul, 37 DEG C of reaction 17min after concussion mixes;It is washed 5 times after reaction, luminous substrate A and luminous bottom is added in each reaction cup Object B mixed liquor 100ul, is protected from light 5min after mixing and is detected.
The ELISA detection kit and HPLC method established with anti-methoxyepinephrine antibody prepared by the present invention It is simultaneously congenital adrenal hyperplasia, hypertension, chromaffin cell tumor, Graves' disease etc. to 40 clinical diagnosises Urine specimen is detected, testing result and HPLC method testing result correlation y=1.1016x+6.6628 as shown in Figure 1:, R2=0.9832。

Claims (5)

1. a kind of preparation method of methoxyepinephrine specific antibody, it is characterised in that: the methoxyl group removes first kidney Upper parathyrine specific antibody is that artificial antigen is prepared using methoxyepinephrine coupling carrier albumen as immunogene, is immunized Experimental animal obtains.
2. the preparation method of methoxyepinephrine specific antibody according to claim 1, it is characterised in that: institute Stating carrier protein is bovine serum albumin(BSA), keyhole limpet hemocyanin or oralbumin.
3. the methoxyepinephrine specific antibody of claim 1 is preparing methoxyepinephrine detection reagent Application in box, it is characterised in that: the antibody of preparation is coated on solid phase carrier, with biotinylated acylating agent by sample into Row processing makes the methoxyepinephrine after being acylated in sample be identified and be combined by the antibody on solid phase carrier;It washes away not In conjunction with acylating agent after, be added use horseradish peroxidase-labeled Avidin;After washing again, substrate solution is added, it is quantitative Detect the content of the methoxyepinephrine in sample.
4. methoxyepinephrine specific antibody as claimed in claim 3 is preparing methoxyepinephrine inspection Application in test agent box, it is characterised in that: the solid phase carrier is magnetic particle or microwell plate;The acylating agent is 6- (dimaleoyl imino) caproic acid succinimide ester, N- [6-(biotin amino) caproyl] -6-aminocaprolc acid N- succinyl are sub- Amine ester or N- succinimide base 6- biotin lpsilon.
5. methoxyepinephrine specific antibody as claimed in claim 3 is preparing methoxyepinephrine inspection Application in test agent box, it is characterised in that: the sample is serum, blood plasma or urine.
CN201910297156.3A 2019-04-15 2019-04-15 A kind of preparation method and applications of methoxyepinephrine specific antibody Pending CN109917144A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201910297156.3A CN109917144A (en) 2019-04-15 2019-04-15 A kind of preparation method and applications of methoxyepinephrine specific antibody

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201910297156.3A CN109917144A (en) 2019-04-15 2019-04-15 A kind of preparation method and applications of methoxyepinephrine specific antibody

Publications (1)

Publication Number Publication Date
CN109917144A true CN109917144A (en) 2019-06-21

Family

ID=66969895

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201910297156.3A Pending CN109917144A (en) 2019-04-15 2019-04-15 A kind of preparation method and applications of methoxyepinephrine specific antibody

Country Status (1)

Country Link
CN (1) CN109917144A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112225672A (en) * 2020-10-16 2021-01-15 湖南苏阳医疗科技有限公司 Methoxy norepinephrine derivative, immunogen, specific antibody, preparation method and application thereof
CN112266330A (en) * 2020-10-15 2021-01-26 湖南苏阳医疗科技有限公司 Methoxy adrenaline derivative, immunogen, anti-methoxy adrenaline specific antibody, preparation method and application thereof

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20120191434A1 (en) * 2010-08-25 2012-07-26 Gt Life Sciences, Inc. Articles of manufacture and methods for modeling chinese hamster ovary (cho) cell metabolism
CN103570824A (en) * 2013-11-25 2014-02-12 博奥赛斯(天津)生物科技有限公司 Preparation method of noradrenaline complete antigen
CN109444402A (en) * 2018-12-18 2019-03-08 郑州安图生物工程股份有限公司 Norepinephrine electrochemiluminescent immunoassay detection kit
CN109444416A (en) * 2018-12-18 2019-03-08 郑州安图生物工程股份有限公司 Methoxyepinephrine electrochemiluminescent immunoassay detection kit
CN109444415A (en) * 2018-12-18 2019-03-08 郑州安图生物工程股份有限公司 Metanephrine electrochemiluminescent immunoassay detection kit

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20120191434A1 (en) * 2010-08-25 2012-07-26 Gt Life Sciences, Inc. Articles of manufacture and methods for modeling chinese hamster ovary (cho) cell metabolism
CN103570824A (en) * 2013-11-25 2014-02-12 博奥赛斯(天津)生物科技有限公司 Preparation method of noradrenaline complete antigen
CN109444402A (en) * 2018-12-18 2019-03-08 郑州安图生物工程股份有限公司 Norepinephrine electrochemiluminescent immunoassay detection kit
CN109444416A (en) * 2018-12-18 2019-03-08 郑州安图生物工程股份有限公司 Methoxyepinephrine electrochemiluminescent immunoassay detection kit
CN109444415A (en) * 2018-12-18 2019-03-08 郑州安图生物工程股份有限公司 Metanephrine electrochemiluminescent immunoassay detection kit

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112266330A (en) * 2020-10-15 2021-01-26 湖南苏阳医疗科技有限公司 Methoxy adrenaline derivative, immunogen, anti-methoxy adrenaline specific antibody, preparation method and application thereof
CN112266330B (en) * 2020-10-15 2023-02-24 长沙博源医疗科技有限公司 Methoxyarenol derivative, immunogen, anti-methoxyadrol specific antibody, preparation method and application thereof
CN112225672A (en) * 2020-10-16 2021-01-15 湖南苏阳医疗科技有限公司 Methoxy norepinephrine derivative, immunogen, specific antibody, preparation method and application thereof
CN112225672B (en) * 2020-10-16 2023-03-28 长沙博源医疗科技有限公司 Methoxy norepinephrine derivative, immunogen, specific antibody, preparation method and application thereof

Similar Documents

Publication Publication Date Title
EP2458378B1 (en) Insulin measurement method
US20060188519A1 (en) Peptides, antibodies, and methods for the diagnosis of SARS
WO2007140696A1 (en) Elisa kit for detecting sudan red and method thereof
KR20100075455A (en) Drug monitoring assay
CN111308084B (en) Detection method and kit for hypersensitive cardiac troponin I
EP2233503A1 (en) Anti-ofloxacin monoclonal antibody and immunoassay method of ofloxacin using the same
CN110818800B (en) Detection method for indirectly detecting target analyte by constructing bridged complex
CA2936805A1 (en) Cell surface prostate cancer antigen for diagnosis
JP2003160599A (en) Antibody against carboxymethylated peptide
CN109917144A (en) A kind of preparation method and applications of methoxyepinephrine specific antibody
JPWO2008059837A1 (en) Antibody against aflatoxin, carrier using the antibody, immunological detection method for aflatoxin, and method for concentrating and purifying aflatoxin
JP2006282547A (en) Hapten compound of nitenpyram, antibody, hybridoma, means for assaying the same and assay kit or assay method
CN112986586A (en) Amino-terminal brain natriuretic peptide detection method and kit
US9116152B2 (en) Monoclonal antibodies which specifically recognize human liver-carboxylesterase 1, hybridoma cell lines which produce monoclonal antibodies, and uses thereof
CN101561439A (en) Nitrofurantoin residue enzyme-linked immunoassay kit
KR101329344B1 (en) Antibody for Detecting Hemagglutinin of Swine Influenza and Use Thereof
KR102227251B1 (en) Monoclonal antibody with specificity for the envelope protein domain Ⅲ of Zika virus, hybridoma cell line producing the same and use thereof
US9541550B2 (en) Method for immunologically measuring soluble LR11
Cernoch et al. Production and analytical characterization of neopterin immunoreagents for biosensor developments
EP3066122B1 (en) Pre-haptoglobin-2 monoclonal antibodies and uses thereof
KR102227257B1 (en) Monoclonal antibody with specificity for the envelope protein domain Ⅲ of flaviviruses, hybridoma cell line producing the same and use thereof
JP2014520825A (en) Β-amyloid x-37 specific for monoclonal antibodies and use thereof
JP2002209579A (en) Anti-human hemoglobin monoclonal antibody, cell line producing the same and kit containing the same for detecting human hemoglobin
WO2023191046A1 (en) Hrg measuring method using anti-hrg monoclonal antibodies
WO2022077931A1 (en) Cardiac troponin i detection method and kit

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20190621